Sean Murphy's Net Worth

$182 Thousand

Estimate Recalculated Sep 13, 2024 09:45PM EST

Who is Sean Murphy

Sean Murphy does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Radius Health, Inc., Poseida Therapeutics, Inc., Novan, Inc., and TriSalus Life Sciences, Inc..

SEC CIK

Sean Murphy's CIK is 0001685042

Past Insider Trading and Trends

2020 was Sean Murphy's most active year for acquiring shares with 3 total transactions. Sean Murphy's most active month to acquire stocks was the month of December. 2022 was Sean Murphy's most active year for disposing of shares, totalling 2 transactions. Sean Murphy's most active month to dispose stocks was the month of July. 2020 saw Sean Murphy paying a total of $160,000.00 for 60,000 shares, this is the most they've acquired in one year. In 2022 Sean Murphy cashed out on 15,500 shares for a total of $91,000.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Radius Health, Inc.

Investor
Updated Aug 15, 2022
Form 4
-100.00%
-15.50K
$6.80
-$91.00K
Aug 15, 2022
Disposition
Aug 15
Form 4
281.82%
15.50K
Jan 25, 2022
21.00K
Grant
Jan 14
Form 4
15.50K
Feb 23, 2021
15.50K
Grant
Feb 22
Form 4
20.00K
Jan 25, 2021
20.00K
Grant
Jan 21
Form 4
30.00K
Aug 12, 2020
30.00K
Grant
Aug 10
Form 3
Aug 12, 2020
Showing 6 results

Poseida Therapeutics, Inc.

Investor
Updated Jul 15, 2020
Form 4
-19.72%
-2.26M
$16.00
$160.00K
Jul 15, 2020
9.20M
Buy-Options
Jul 14
Form 4
20.00K
Jul 13, 2020
20.00K
Grant
Jul 09
Form 3
Jul 09, 2020
Showing 3 results

Novan, Inc.

Investor
Updated Jun 07, 2018
Form 4
20.00K
Jun 07, 2018
20.00K
Grant
Jun 04
Form 4
34.01K
Jun 07, 2017
34.01K
Grant
Jun 05
Form 4
14.48K
Sep 22, 2016
14.48K
Grant
Sep 20
Form 3
Sep 20, 2016
Showing 4 results

TriSalus Life Sciences, Inc.

CHIEF FINANCIAL OFFICER
Updated Feb 14, 2024
Form 4
836.00%
139.14K
Feb 14, 2024
681.06K
Grant
Feb 12
Form 4
125.00K
Jan 25, 2024
125.00K
Grant
Jan 24
Form 4
62.50K
Aug 14, 2023
62.50K
Grant
Aug 11
Form 3
Aug 14, 2023
541.91K
Showing 4 results